Document Download

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Author / Organization: McGovern AJ, Cinfio F, Luo R

File Format PDF (Portable Document Format)
Publication Year 2026
Source Host PubMed Central (pmc.ncbi.nlm.nih.gov)
License / Terms Open Access / Creative Commons

Ready for Immediate Access

Your selected document is ready for instant access with zero mandatory waiting period.

Alternative Options: Download via MainReads Proxy Read Online in PDF.js Viewer Open Source Website »
Advertisement
SPONSOR CONTENT
Linking & Access Policy: MainReads provides direct outbound links to documents and educational resources hosted by original source repositories, universities, and open libraries. Downloads are never made conditional on advertisements or user registrations. If you encounter an inaccessible or broken resource link, please use the Report Broken Link feature on the catalog page.
« Return to Document Detail & Online Reader